Commissioning commences as Kiniéro tracks towards Q4 first gold

Highlights: Commissioning and operations team fully mobilised to site at Kiniéro Gold Project as Robex prepares for first ...

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive top-line results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® ...